Wednesday, 23 December 2015

Erectile Dysfunction Drugs Market Analysis, Size, Segment To 2022 by Grand View Research, Inc.



The global erectile dysfunction drugs market is expected to reach USD 3.2 billion by 2022 according to a new report by Grand View Research Inc. Rising adoption of sedentary lifestyle and increasing prevalence of conditions causing erectile dysfunction such as stress, hypertension, and related medications are the key factors expected to widen the target population base for this market.
However, the market is estimated to witness decline in revenue over the forecast period. Expiration of key drugs from 2017 to 2019 is likely to curb revenue growth. On the other hand, the market is likely to open up new avenues for the generic manufacturers to capitalize on. The increasing risk of sexually transmitted diseases, narrowing of insurance coverage for erectile dysfunction treatment, growing threat from counterfeit drugs, and presence of social stigma in developing countries are some factors limiting penetration rates.

North America erectile dysfunction drugs market, by product, 2012-2022, (USD Million)
North America erectile dysfunction drugs market 

Further key findings from the report suggest:
  • Viagra accounted for over 47.0% of the total revenue in 2014. It is generally considered as the first line of treatment for erectile dysfunction. Brand loyalty and advantages associated with this drug such as high efficacy, and effectiveness are the major factors attributing for its large market share.
  • Cialis (tadalafil) from Eli Lilly & Co. and Levitra (vardenafil) from Bayer AG are known to be the competitors for Viagra globally. Cialis (tadalafil) was approved in 2003 by the U.S. FDA, as a prescription drug in the U.S. Cialis is also known as “The Weekend Pill” owing to its 36-hour effectiveness.
  • After the patent expiration of key drugs such as Cialis (tadalafil) in 2017 and Levitra (vardenafil) in 2018, other drugs such as Stendra/Spedra, Zydena (udenafil), and Vitaros (Alprostadil Cream) are expected to capture the market share during the forecasts period.
  • North America constituted the largest share of approximately 55.0% in 2013 of the total erectile dysfunction market. Extension of patent exclusivity rights for Viagra (sildenafil citrate) in the U.S. till 2019 along with introduction of new erectile dysfunction drugs such as Zydena (udenafil) and Stendra/Spedra (avanafil) will be the major factors responsible for market growth during the forecasts period.
  • Asia Pacific accounted for a revenue share of over 16.5% in 2012 owing to the presence of a lucrative market for generic drugs, untapped opportunities, and increasing awareness related to erectile dysfunction in this region
  • Apricus Biosciences Inc., Cristalia Produtos Quimicos Farmaceuticos Ltd., Bayer AG, Dong-A Pharmaceutical Co. Ltd., Meda Pharmaceuticals, Inc., Eli Lilly and Company, Pfizer, Inc., S.K. Chemicals Co. Ltd., and Vivus, Inc. are some major players of this market
  • Extensive R&D carried out by companies and high unmet needs in developing economies are expected to boost industrial growth. Key manufacturers are targeting regions with unmet clinical needs by entering into agreement with local manufacturers and distributors. Key players are constantly engaged in developing novel drugs in an attempt to improve the presence and ensure sustainability. 
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global erectile dysfunction drugs market on the basis of product and region:
Erectile Dysfunction Drugs Product Outlook (Revenue, USD Million, 2012 – 2022)
  • Viagra (sildenafil citrate)
  • Cialis (tadalafil)
  • Levitra/Staxyn (vardenafil)
  • Stendra/Spedra (avanafil)
  • Zydena (udenafil)
  • Vitaros (Alprostadil Cream)
  • Others
Erectile Dysfunction Drugs Regional Outlook (Revenue, USD Million, 2012 – 2022)
  • North America
  • Europe
  • Asia Pacific
  • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:

Cord Blood Banking Service Market Share, Competitive Strategies, Regional Outlook, Market Demand 2015 To 2022



The global market for cord blood banking (CBB) service is expected to reach over USD 12 billion by 2022, growing at an estimated CAGR of around 11% from 2015 to 2022, according to a new report by Grand View Research, Inc. Key drivers of the market include increasing application of stem cell therapy in disease treatment, and rising prevalence of life threatening genetic disorders.
Moreover, increasing spending capacity is fueling the demand for advanced healthcare facilities including prevention and treatment. As a result, parents are increasingly demanding CBB Service to ensure safety of their child’s future. Furthermore, private players are practicing marketing activities which are creating awareness about the availability of the CBB Service and their benefits.
In addition, governments worldwide are promoting public CBB to develop ethnically diverse cord blood repository which would increase the chances of finding suitable human leukocyte antigen (HLA) match for the patients. As a result, availability of the ethnically rich CB repository coupled with anticipated rise in the stem cell therapies and bone marrow transplants, is expected to spur the CBB Service during the forecast period.
Further key findings from the study suggest:
  • Private bank segment accounted for the largest market share in 2014. High cost of collection, processing, and storage along with the maximum awareness created by marketing activities practiced by the players resulted in large market share of private banks in the world. 
  • Rising government support and no storage and collection costs are the major factors anticipated to drive the public banking segment during the forecast period from 2015 to 2022 with highest CAGR.  
  • North America dominated the global market and was followed by Europe in 2014. Dominance of North America is accounted by government support and high penetration rate of stem cell therapy in the U.S. and Canada. Moreover, high awareness and insurance coverage of cord blood banking and stem cell therapies is further boosting the growth of the market in North America.
  • Densely populated emerging countries of Asia Pacific are anticipated to show significant growth during the forecast period from 2015 to 2022. Factors such as increasing investment by global players, government support and rising healthcare expenditure are anticipated to boost the cord blood banking Service market in Asia Pacific.
  • Global cord blood banking Service market is highly fragmented with presence of many private and public players. Few global players operate in various geographies through subsidiaries. While local players are operating independently in respective geographies.
  • Key players of this market include China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Limited, Cryo-Cell International, Inc., Cryo-Save AG, Lifeforce Cryobanks, National Cord Blood Program, ViaCord, Inc. and Virgin Health Bank 
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/biotechnology
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:

Tuesday, 22 December 2015

Guidewires Market Size, Analysis To 2020: Grand View Research, Inc.



Global guidewires market is expected to reach USD 2,197.2 million by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of target diseases coupled with growing geriatric population base is expected to drive guidewire demand over the next six years. Technology innovation across various product segments, in terms of flexibility, tip retention etc. is also expected to boost market demand by catering to the requirements of healthcare practitioners.
Coronary guidewires dominated the overall market in terms of revenue, estimated at USD 700.1 million in 2013. Coronary guidewires market is expected to grow on account increasing prevalence of cardiovascular diseases and the presence of high minimally invasive coronary procedure volumes. 
Further key findings from the study suggest:
  • Global guidewires demand was 16,645.9 thousand units in 2013 and is expected to reach 25,640.2 thousand units by 2020, growing at a CAGR of 6.4% from 2014 to 2020. 
  • Peripheral guidewires are expected to remain as the second largest product segment after coronary guidewires during the forecast period. In terms of revenue, the market for peripheral guidewires is expected to grow at a CAGR of over 6.0% from 2014 to 2020 due to increasing prevalence of peripheral vascular diseases (PVDs), peripheral artery diseases (PADs), abdominal aortic aneurysms (AAA) and carotid artery stenosis (CAS).
  • North America dominated the overall market in terms of revenue share in 2013 majorly on account of the presence of high prevalence levels of cardiovascular and neurovascular disorders and sophisticated healthcare infrastructure
  • Asia Pacific is expected to be the fastest growing regional market for guidewires, driven by increasing demand for medical tourism in emerging markets of India and China and rapidly improving healthcare infrastructure.
  • Some key market players of guidewires include Terumo Corporation, ASAHI INTECC, Abbott Laboratories, Medtronic Inc., Cordis Corporation, Boston Scientific Corporation, Covidien, B. Braun and Cook Medical.
  • R&D spending has steadily increased over the last three years, in an attempt to develop technologically advanced and cost effective products and avoid barriers such as product recalls. In addition, R&D is also focused on the unmet needs of healthcare practitioners in consideration. Tip shape retention, flexibility and minimal wire perforation are the key requirements of healthcare practitioners.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
For the purpose of this study, Grand View Research has segmented the global guidewires market on the basis of product and region:
Global Guidewires Product Outlook (Volume, Thousand units; Revenue, USD Million, 2012 – 2020)
            • Coronary Guidewire
            • Peripheral Guidewire
            • Neurovascular Guidewire
            • Urology Guidewire
Guidewires Regional Outlook (Volume, Thousand units; Revenue, USD Million, 2012 – 2020)
            • North America
            • Europe
            • Asia Pacific
            • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/



Posted by at No comments:

Deep Brain Stimulators Market Growth, Share, Trends To 2020



Global Deep Brain Stimulators Market is expected to reach USD 1.59 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of target neurological disorders such as Parkinson’s and demand for minimally invasive surgical procedures are some primary factors expected to drive the deep brain stimulators market. Deep brain stimulators have witnessed a significant rise in usage rates and are now considered viable substitutes to conventional therapies. Higher efficacy exhibited by the former is a key reason attributing to the aforementioned conclusion. Introduction of technological advancements such as fractionation of electric current and selective current steering are also expected to improve device usage rates.
Deep brain stimulators are FDA approved when it comes to treating Parkinson’s, dystonia and OCD (obsessive compulsive disorder) etc. Moreover, the use of these devices for diseases such as trigeminal neuralgia, Tourette syndrome, Alzheimer’s, refractory epilepsy, cluster headache and movement disorders by multiple sclerosis are awaiting FDA approval. The potential inclusion of new application areas is expected fuel the future growth of the market. 
Further key findings from the study suggest:
• Parkinson’s disease was the largest application segment of the market in 2013. Use of deep brain stimulators for treating this disease renders symptomatic relief from medicine induced dyskinesia and therefore, these devices are expected to witness a rapid growth in demand during the forecast period.
• OCD (obsessive compulsive disorder) was also one of the leading application segments in 2013. DBS has proven to be the most efficient treatment option pertaining to OCD and is expected to witness a rapid growth in usage rates over the next six years.
• North America was the largest regional market, accounting for over 50.0% of market share in 2013. Presence of sophisticated healthcare infrastructure and reimbursement policies and increasing awareness levels of patients and healthcare personnel are some key factors expected to drive regional market growth during the forecast period.
• Asia Pacific is identified as the most lucrative market. Rapidly improving healthcare infrastructure, presence of high unmet medical needs and increasing healthcare spending levels in the emerging markets of China and India are some factors attributing to its growth.
• Some key manufacturers of deep brain stimulators include St. Jude Medical, Medtronic Plc, Boston Scientific Corporation and Aleva Neurotherapeutics SA.
• The market is marked by the presence of extensive R&D investments targeting the development of technologically advanced systems catering to new application areas. Moreover, manufacturers participate in endeavors directed towards capitalizing on the untapped opportunities available in the emerging Asia Pacific and Latin American markets.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
For the purpose of this study, Grand View Research has segmented the global deep brain stimulators market on the basis of application and region:
Global Deep Brain Stimulators Application Outlook (Revenue, USD Million, 2012 – 2020)
    • Pain Management
    • Epilepsy
    • Essential Tremor
    • Obsessive Compulsive Disorder (OCD)
    • Depression
    • Dystonia
    • Parkinson’s Disease
    • Others
Deep Brain Stimulators Regional Outlook (Revenue, USD Billion, 2012 – 2020)
    • North America
        • U.S.
    • Europe
        • Germany
        • UK
    • Asia Pacific
        • Japan
    • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/



Posted by at No comments:
Subscribe to: Posts (Atom)